HOME › DRUGS › GILTERITINIB
ACTIVE SUBSTANCE / INN

GILTERITINIB

Brand name(s): Xospata
EMA LISTED
AUTHORISED
Leukemia, Myeloid, Acute
ACTIVE SUBSTANCE
Gilteritinib
REGULATORS
EMA
SPONSORS / MAH
Astellas Pharma Europe B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
XospataAstellas Pharma Europe B.V.Authorised24/10/2019Leukemia, Myeloid, Acute

FULL INTELLIGENCE ON GILTERITINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →